Abstracts

ACCELERATED CEREBRAL BLOOD-FLOW REDUCTION AND BRAIN AGING IN PEOPLE LIVING WITH HIV

People living with HIV (PLWH) are characterized by altered brain structure and function. As they attain normal lifespans, it remains unclear whether HIV accelerates aging in select subgroups. Additionally, the relationship between viral load (VL) and brain aging has not been fully investigated. Three groups were evaluated: HIV uninfected (HIV-) controls (n=206), PLWH with undetectable…

VASCULAR INJURY MARKERS ASSOCIATED WITH COGNITIVE IMPAIRMENT IN HIV PATIENTS ON ART

HIV-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on current antiretroviral therapy (ART). Cerebrovascular disease contributes to HAND, but biomarkers that distinguish vascular cognitive impairment from other types of HAND remain unclear. In this cross-sectional study, we investigated relationships between plasma and CSF vascular, inflammation, and CNS injury markers, HAND, and cerebrovascular disease in…

BASELINE MONOCYTE HIV RNA PREDICTS BLUNTED COGNITIVE TRAJECTORIES IN ACUTE INFECTION

Even when instituted during acute HIV infection (AHI), antiretroviral therapy (ART) does not completely prevent brain injury. Peripheral biomarkers of monocyte/macrophage activation are strong indicators of brain abnormalities in HIV. Whether early establishment of HIV in monocytes contributes to viral persistence and brain injury remains unknown. Here we determined the detectability of HIV RNA in…

GlycA IS ASSOCIATED WITH NEUROPSYCHOLOGICAL IMPAIRMENT IN PREDOMINANTLY HIV+ MEN

Neuropsychological impairment (NPI) remains prevalent among people with HIV (PWH) in the combination antiretroviral therapy (ART) era. The mechanisms for NPI during ART remain unclear, but accumulating evidence suggests that chronic inflammation may have a role. GlycA, a novel blood biomarker representing the nuclear magnetic resonance signal from glycosylated acute phase reactants, is associated with…

PREDICTED PATHOGENICITY OF mtDNA VARIANTS AND MOTOR IMPAIRMENT IN PERSONS WITH HIV

Mitochondrial DNA (mtDNA) variation is associated with neurocognitive (NC) impairment (NCI) in persons with HIV. Prior studies have focused on mtDNA haplogroups. Recent models consider the cumulative impact of mtDNA variants predicted to be deleterious. MutPred software uses sequence conservation and protein structure to predict the impact of mtDNA variants on protein function. We examined…